DKK1 and Alzheimer disease: In AD, these processes are disrupted, and indeed, Wnt/β-catenin signalling is down-regulated, and antagonists, such as DKK1 and DKK3, are upregulated (Flores et al., 2024; Inestrosa and Varela-Nallar, 2014; Purro et al., 2012).